British American Tobacco (BTI) subsidiary Reynolds issued a formal response to U.S. senators on July 2, 2026. The correspondence addresses the Food and Drug Administration's (FDA) May 2026 guidance regarding enforcement priorities for unauthorized electronic nicotine delivery systems (ENDS).
Senators Dick Durbin and Elizabeth Warren sent a letter in June questioning the new FDA policy. They alleged the guidance allows unauthorized flavored e-cigarettes to remain on the market as a lucrative payday following political contributions.
BTI initiated the correspondence to engage lawmakers on these regulatory issues. The company stated the letter clarifies its position on compliance and consumer safety during the transition of its next-generation product portfolio.